The news came just weeks after the FDA warned against treating COVID-19 with hydroxychloroquine “outside of the hospital setting or a clinical trial” due to significant cardiovascular complications.
The news came just weeks after the FDA warned against treating COVID-19 with hydroxychloroquine “outside of the hospital setting or a clinical trial” due to significant cardiovascular complications.
Evolocumab is an effective treatment option for patients with a recent myocardial infarction (MI), according to new findings published in JAMA Cardiology.
Evolocumab is an effective treatment option for patients with a recent myocardial infarction (MI), according to new findings published in JAMA Cardiology.
The Association of Black Cardiologists (ABC) has shared resources for patients and healthcare providers focused on COVID-19’s impact on black communities and other underserved patient populations.
The Association of Black Cardiologists (ABC) has shared resources for patients and healthcare providers focused on COVID-19’s impact on black communities and other underserved patient populations.
The Society of Cardiovascular Angiography and Interventions (SCAI) has shared a new guidance detailing the management of patients with out-of-hospital cardiac arrest (OHCA).
The Society of Cardiovascular Angiography and Interventions (SCAI) has shared a new guidance detailing the management of patients with out-of-hospital cardiac arrest (OHCA).
Cardiac cath labs can achieve significant radiation dose reductions through focused, collaborative quality improvement (QI) efforts, according to a new analysis published in Circulation: Cardiovascular Interventions.
Cardiac cath labs can achieve significant radiation dose reductions through focused, collaborative quality improvement (QI) efforts, according to a new analysis published in Circulation: Cardiovascular Interventions.
